Go Pro
→ The trade I’ve been waiting for since 2011 (From Traders Agency) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
$4.59
-1.9%		$6.11
$2.44
▼
$32.55
$4.46M-12.51 million shs65,858 shs
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.57
+1.9%		$0.96
$0.54
▼
$2.89
$1.57M0.89867,362 shs15,190 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$5.06
-5.6%		$10.71
$4.72
▼
$60.00
$3.71M3.9510,201 shs14,239 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.20
$0.84
$0.02
▼
$1.20
$5.73M1.81,390 shsN/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
0.00%-13.72%-62.28%-46.69%-81.48%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00%-7.58%-38.18%-53.79%-72.54%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.00%-32.53%-50.19%-67.79%-79.92%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%+20.00%+20.00%+100.00%+2,976.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
$4.59
-1.9%		$6.11
$2.44
▼
$32.55
$4.46M-12.51 million shs65,858 shs
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.57
+1.9%		$0.96
$0.54
▼
$2.89
$1.57M0.89867,362 shs15,190 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$5.06
-5.6%		$10.71
$4.72
▼
$60.00
$3.71M3.9510,201 shs14,239 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.20
$0.84
$0.02
▼
$1.20
$5.73M1.81,390 shsN/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
0.00%-13.72%-62.28%-46.69%-81.48%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00%-7.58%-38.18%-53.79%-72.54%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.00%-32.53%-50.19%-67.79%-79.92%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%+20.00%+20.00%+100.00%+2,976.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
2.00
Hold$42.00815.03% Upside
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
1.00
SellN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
1.00
SellN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BBLG, SONX, NXL, and AMIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/28/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
7/24/2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/10/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
7/8/2026
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/23/2026
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/A$3.26 per shareN/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$1.42 per shareN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$217.16K17.10N/AN/A$2.07 per share2.44
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.13N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-$16.72M-$41.57N/AN/AN/AN/A-267.73%-216.75%11/11/2026 (Estimated)
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$3.11M-$1.37N/AN/AN/AN/A-57.87%-53.65%11/13/2026 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$8.22M-$14.41N/AN/AN/A-4,141.94%-278.24%-218.42%N/A
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$71.12N/AN/AN/A-92.74%-184.01%-68.60%11/11/2026 (Estimated)

Latest BBLG, SONX, NXL, and AMIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$0.39-$0.43-$0.04-$0.43N/AN/A
8/12/2026Q1 2027
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
-$6.40-$5.02+$1.38-$5.02N/AN/A
8/12/2026Q2 2026
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$3.00-$0.11+$2.89-$3.30$0.09 million$0.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/AN/AN/AN/AN/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
N/A
4.85
4.85
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/A
8.67
8.67
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
1.25
1.10
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
10.78%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
34.30%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
6.20%
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
5.60%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
16.94%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
1970,000911,000N/A
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
22.76 million2.60 millionNot Optionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3734,000610,000Not Optionable
Sonendo, Inc. stock logo
SONX
Sonendo
2504.78 million393,000Not Optionable

Recent News About These Companies

Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even
August 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260825390808/en/sonendo-announces-key-initiatives-to-drive-business-towards-cashflow-break-even/
Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024
June 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20241029781245/en/Sonendo-Inc.-to-Report-Third-Quarter-2024-Financial-Results-on-November-12-2024
Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga
April 8, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SONX
Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
March 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260316143036/en/sonendo-inc.-on-path-to-breakeven-in-the-second-half-of-2026/
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...
August 22, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer
Sonendo names John McGaugh COO
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sonendo-names-john-mcgaugh-coo/ar-AA1KU4kG
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
August 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer/
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
August 13, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250813720540/en/sonendo-inc.-reports-second-quarter-2025-financial-results-and-reaffirms-financial-guidance/
Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
June 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250604534828/en/Sonendo-Inc.-Reports-First-Quarter-2025-Financial-Results-and-Issues-Financial-Guidance/
Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250326534061/en/sonendo-inc.-reports-fourth-quarter-and-full-year-2024-financial-results/
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
November 11, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241111083660/en/sonendo-inc.-to-release-third-quarter-2024-financial-results-and-postpone-conference-call-on-november-12-2024/
Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
November 5, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2364453/sonendo-inc-sonx-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2364453
Sonendo Launches ProControlTM for the GentleWave® G4 System
October 23, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241023284533/en/sonendo-launches-procontroltm-for-the-gentlewave%c2%ae-g4-system/
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
October 10, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241010657314/en/sonendo-inc.-announces-preliminary-third-quarter-2024-financial-results/
BIOLASE files for Chapter 11, plans asset sale to Sonendo
October 3, 2024  |  investing.comhttps://www.investing.com/news/company-news/biolase-files-for-chapter-11-plans-asset-sale-to-sonendo-3643778
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
August 27, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2327671/here-s-why-sonendo-sonx-is-a-great-buy-the-bottom-stock-now?cid=cs-stocknewsapi-ft-tale_of_the_tape|hammer_chart_pattern_(ta)-2327671
Sonendo Inc.
August 17, 2024  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SONX/financials/secfilings
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
August 10, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4713322-sonendo-inc-sonx-q2-2024-earnings-call-transcript
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
August 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2318510/sonendo-inc-sonx-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2318510
Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance
August 7, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/sonendo-inc-reports-second-quarter-200500745.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Autonomix Medical stock logo

Autonomix Medical NASDAQ:AMIX

$4.59 -0.09 (-1.92%)
As of 09/4/2026 04:00 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$0.57 +0.01 (+1.86%)
As of 09/4/2026 04:00 PM Eastern

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$5.06 -0.30 (-5.60%)
As of 09/4/2026 04:00 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Sonendo stock logo

Sonendo NYSE:SONX

$1.20 0.00 (0.00%)
As of 09/4/2026

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas